GSLDT · Registering as Listener

Global Summit on Liver Diseases and Therapeutics

26th Apr – 27th Apr 2027 Nairobi, Kenya Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceGSLDT
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

Global Summit on Liver Diseases and Therapeutics conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 2 - Zero Hunger SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 6 - Clean Water and Sanitation

This session will explore the latest diagnostic techniques and biomarkers for liver diseases. Emphasis will be placed on improving early detection and patient outcomes.

This track will focus on novel therapeutic approaches and drug developments targeting various liver diseases. Discussions will include pharmacological advancements and their clinical implications.

This session will examine the role of physiotherapy in managing liver disease patients. Evidence-based practices and rehabilitation strategies will be highlighted.

This track will address the relationship between infectious diseases and liver health. Topics will include viral hepatitis, co-infections, and their management.

This session will delve into the importance of nutrition in the prevention and management of liver diseases. Participants will discuss dietary interventions and their clinical relevance.

This track will present cutting-edge research findings in the field of hepatology. Researchers will share insights into ongoing studies and future directions.

This session will focus on the importance of a patient-centered approach in managing liver diseases. Strategies for enhancing patient engagement and compliance will be discussed.

This track will explore public health initiatives aimed at preventing liver diseases globally. Discussions will include awareness campaigns and policy implications.

This session will investigate the psychosocial challenges faced by patients with liver diseases. The impact of mental health on treatment adherence and quality of life will be examined.

This track will highlight the role of technology in the diagnosis and treatment of liver diseases. Innovations such as telemedicine and digital health tools will be discussed.

This session will provide insights into liver disease research from a global perspective. Researchers will share their findings and discuss collaborative opportunities across borders.

COPYRIGHT © 2026 Global Summit on Liver Diseases and Therapeutics. ALL RIGHTS RESERVED